![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
Insights from JP Morgan 2025: Key trends shaping the pharma …
3 小时之前 · Tune in to the latest insights from JP Morgan Healthcare 2025 in this exclusive podcast interview, exploring key trends shaping the pharmaceutical industry. Stay informed and ahead of the curve.
2025: The year ahead in pharma and life sciences | pharmaphorum
3 天之前 · Discover the key trends and innovations shaping the pharma and life sciences industries in 2025, focusing on efficiency, patient care, customer experience, and advancements in rare disease treatments.
Key trends shaping pharmaceutical operations in 2025
2025年1月30日 · Stay ahead of the curve by exploring the key trends shaping pharmaceutical operations in 2025, including cybersecurity, efficiency, workforce management, and technology advancements. Learn more ...
Life Sciences Industry Report 2025 | pharmaphorum
2025年1月9日 · In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical industry along in 2024.
News | Timely industry updates for pharma and biotech leaders
3 天之前 · pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
pharmaphorum - The Deep Dive Digital Magazine has fresh …
2024年2月28日 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
About pharmaphorum
6 天之前 · pharmaphorum.com is a leading online destination for healthcare and pharmaceutical industry news, insight, and debate – as is its associated digital magazine Deep Dive. www.pharmaphorum.com
Life Sciences Industry Report 2025 - Part 2 | pharmaphorum
2025年1月14日 · Life Sciences Industry Report - Part 6. There are some 7,000 known rare diseases in the world, yet, multiple challenges and unmet needs remain when it comes to therapies for these diseases.
The biopharma outlook for 2025: Opportunities and challenges
2025年1月8日 · Boost to Enhertu's prospects as FDA clears Roche diagnostic. Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi ...